About Event
Welcome to the Inaugural Tumour Models Summit Nordics!
Dedicated to Improving Target Selection, Facilitating Biomarker Discovery & Achieving Clinical Translatability
Preclinical oncology research continues to face significant hurdles, with over 80% of phase III clinical trials failing to yield effective treatments. To bridge the gap, the development of accurate models to reflect cellular and molecular diversity is essential for improving drug discovery and therapeutic testing.
The inaugural Tumour Models Nordics Summit is your chance to join a dynamic community of 70+ industry leaders from Preclinical, Translational, Discovery, Toxicity, and Biology development teams. This event is dedicated to fostering discussions on best practices for optimizing and implementing oncology models with greater translatability to clinical outcomes.
What You’ll Gain
Dive into the latest advancements in:
  Accelerating drug development pipelines by validating next-generation cancer models tailored for precision oncology
  Harnessing patient-derived xenografts (PDX) and personalised systems to improve translational accuracy & treatment outcomes
  Discovering and implement cutting-edge biomarker strategies to enhance predictive power and treatment selection
  Integrating multi-omics technologies to maximise model relevance and unlock actionable insights for cancer therapies
Learn directly from industry pioneers, including Anocca, Roche, Adcendo, Sprint Biosciences and Biovent, as they share their expertise in transforming cancer research and therapeutics development.
Why Attend?
Here’s a glimpse of what awaits:
Complimentary Access for Drug Developers & Academics
Pioneering Approaches in Tumour Models
Expand Your Network
Enjoy exclusive, free attendance to advance your translational research and accelerate pipeline development. This offer is specifically designed for professionals in the Nordic region to connect with leading tumour model providers, ensuring you identify the most effective platforms for your studies.
Gain valuable insights from case studies on:
Take part in tailored networking opportunities, including a speed networking session, to exchange challenges, share insights, and inspire solutions that advance clinical confident and relevance in tumour models research.
What Experts Are Saying
"The Tumour Models Summit Nordics provides actionable insights to enhance preclinical model translatability, refine workflows, and build strategic partnerships to drive advancements in precision oncology and increase clinical confidence"
- Chief Scientific Officer | CuraCell